Whole-cell electrophysiology demonstrates cholesterol inhibits TRPM3 activation, suggesting a competitive interaction with pregnenolone sulphate.
Cholesterol is a major constituent of the plasma membrane, here it interacts with many ion channels and has been described to confer a net inhibitory effect. The nociceptive ion channel TRPM3 is involved in pain and heat sensation. In recent solved structures, it has been shown that cholesterol-like molecules are found in important agonist binding pockets. This led to the hypothesis that cholesterol may be competitive with channel agonists. Here, we use whole-cell electrophysiology on heterologous TRPM3 expressing 293-HEK cells to demonstrate that cholesterol not only inhibits channel activation but also appears to be competitive with the channel agonist pregnenolone sulphate. This work will hopefully precede a better understanding of how TRPM3 maintains the closed state in the physiological plasma membrane, which can later be leveraged for therapeutic avenues.
No takes yet. Share an insight, caveat, or question.
Denley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: